CAS: 485-49-4; (R)-6-((S)-6-Methyl-5,6,7,8-Tetrahydro-[1,3]Dioxolo[4,5-G]Isoquinolin-5-yl)-[1,3]Dioxolo[4,5-E]Isobenzofuran-8(6H)-One

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号50-00-0 甲醛 | CAS号56083-00-2 (+)-bicuculline | CAS号64395-07-9 Furo[3,4-e]-1,3... | CAS号58343-48-9 5-formyl-1,3-be... | CAS号185022-35-9 N-(2-(benzo[d][... | CAS号40709-69-1 (-)-双环甲硫脲

合成工艺路线路线简述

    5-Formyl-Benzo[1,3]Dioxole-4-Carboxylic Acid置于盐酸,Sodium Hydroxide,Sodium Tetrahydroborate,甲酸,氯化亚砜,硫酸,溶剂黄146,三氯氧磷体系中,用 二氯甲烷,苯 作为反应溶剂,化学反应 15.25H,反应生成 (+)-荷包牡丹碱
    参考文献:双瓜氨酸和去甲胆碱对映异构体的合成,抗gaba活性和优选构象.
    标题:双瓜氨酸和去甲胆碱对映异构体的合成,抗gaba活性和优选构象.
    摘要:使用bischler-Napieralski环化作为关键步骤,从胡椒醛中合成了赤型-(+/-)-[1Sr,9Rs]-核苷和苏型-(+/-)-[1Sr,9Sr]-去甲rad啶.拆分产生对映体纯度> 99.5%的(+)-[1S,9R]-冰核碱([1S,9R] Norbic)和(-)-[1R,9S]-冰核碱([1R,9S] Norbic).通过将后面的产物甲基化,可以容易地获得双瓜氨酸对映异构体.作为抑制gaba(a)受体结合的抑制剂,[1S,9R] Bic的效力比[1R,9S] Bic的效力高约70倍,在ph 7.1和5.0时,[1S,9R] Bic的效力比[1S,9R] Norbic约高100到900倍分别.同样,[1S,9R] Norbic作为[1S,9R] Bic作为gaba特异性(36)cl(-)离子通量的抑制剂的效力要低得多.观测到[1S中,由n2-Ch(3)取代引起的体外生物活性增加了大约两个数量级,
    DOI:10.1016/0223-5234(96)83969-9

    海关参考信息

    专利信息


    专利号:US-2022160788-A1
    优先权日:2019-03-22
    标题 :Bifunctional vectors allowing bcl11a silencing and expression of an anti-sickling hbb and uses thereof for gene therapy of b-hemoglobinopathies
    发明人:MICCIO ANNARITA; AMENDOLA MARIO; BRUSSON MÉGANE; CAVAZZANA MARINA; MAVILIO FULVIO
    权利人:INST NAT SANTE RECH MED; UNIV DEVRY VAL DESSONNE; ASSIST PUBLIQUE HOPITAUX PARIS APHP; UNIV PARIS; FOND IMAGINE
    摘要:The #β-hemoglobinopathies #β-thalassemia (BT) and sickle cell disease (SCD) are the most frequent genetic disorders worldwide. These diseases are caused by mutations causing reduced or abnormal synthesis of the β-globin chain of the adult hemoglobin (Hb) tetramer. Here, the inventors intend to improve HSC-based gene therapy for β-thalassemia and SCD by developing an innovative, highly infectious LV vector expressing a potent anti-sickling β-globin transgene and a second biological function either increasing fetal γ-globin expression (for β-thalassemia and SCD). More particularly, the inventors have designed a novel lentivirus (LV), which carry two different functions: βAS3 gene addition and gene silencing. This last strategy allows the re-expression of the fetal γ-globin genes (HBG1 and HBG2) and production of the endogenous fetal hemoglobin (HbF). Elevated levels of HbF and HbAS3 (Hb tetramer containing βAS3-globin) will benefit the β-hemoglobinopathy phenotype by increasing the total amount of β-like globin that will: (i) reduce the alpha precipitates and improve the alpha/non alpha ratio in β-thalassemia, and (ii) reduce the sickling in SCD. This combined strategy will improve the β-hemoglobinopathy phenotype at a lower vector copy number (VCN) per cell compared to a LV expressing the βAS3 alone.

    专利号:US-6409988-B1
    优先权日:1999-07-01
    标 题:Radiolabeled 1-aryl pyrazoles, the synthesis thereof and the use thereof as pest GABA receptor ligands
    发明人:DHANOA DALJIT S; MEEGALLA SANATH; DOLLER DARIO; SOLL RICHARD M
    权利人:DIMENSIONAL PHARM INC
    摘要:The present invention is directed to radiolabeled compounds of Formula I:or salts thereof, whereR1 represents R8, R8O, R8SO2, R8SO or R8S in which R8 is tritiated or deuterated methyl;X is halo, cyano, C1-6 alkoxycarbonyl, C2-6 alkynyl, optionally substitutedC6-14 aryl or an optionally substituted 5- to 7-membered heteroaromatic ring linked to thiazole via a carbon-carbon bond;R2 is hydrogen or amino; andR3-R7 are defined in the specification.The invention is also directed to methods of using such compounds for demonstrating specific insect GABA receptors, qualitatively screening for compounds acting on an insect GABA receptor or quantitatively assaying concentrations of a compound acting on an insect GABA receptor.

    专利号:US-2006287397-A1
    优先权日:2002-04-26
    标 题:Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity
    发明人:MEZA TOLEDO SERGIO E
    权利人:MEZA TOLEDO SERGIO E
    摘要:New anticonvulsant compounds were synthesized and they include the compounds: DL-2-hydroxy-2-(3′,5′-bistrifluoromethylphenyl)butyramide, DL-2-hydroxy-2-(4′-trifluoromethylphenyl)butyramide, DL-2-hydroxy-2-(3′,4′-dichlorophenyl)butyramide, DL-2-hydroxy-2-(3′-bromophenyl)butyramide, DL-2-hydroxy-2-(4′-bromophenyl)butyramide, DL-2-hydroxy-2-(3′-nitrophenyl)butyramide, DL-3-hydroxy-3-(3′,4′-dichlorophenyl)pentanamide, DL-3-hydroxy-3-(4′-bromophenyl)pentanamide, DL-4-hydroxy-4-(3′,4′-dichlorophenyl) hexanamide and DL-4-hydroxy-4-(4′-bromophenyl)hexanamide. They have a significant anticonvulsant activity against pentylenetetrazol-induced seizures as well as unexpected differences in anticonvulsant activity respect those of the non-halogenated compounds. The invention further provides methods for the synthesis of the DL-hydroxy-alkyl-phenyl amides as exemplified in the examples.

    专利号:WO-0040532-A2
    优先权日:1998-12-31
    标 题:Synthesis of dihydrohonokiol compositions

    专利号:US-6518266-B1
    优先权日:1999-07-22
    标题:1- Aryl-3-thioalkyl pyrazoles, the synthesis thereof and the use thereof as insecticides
    发明人:DHANOA DALJIT S; DOLLER DARIO; MEEGALLA SANATH; SOLL RICHARD M; WISNEWSKI NANCY; SILVER GARY; STINCHCOMB DAN T; SEWARD R LEE; AGRAFIOTIS DIMITRIS; SHA DEYOU
    权利人:DIMENSIONAL PHARMACEUTICALS 3; HESKA CORP
    摘要:The present invention is directed to novel pyrazole derivatives and their use as pesticidal agents. The pyrazole derivatives have Formula I:or a salt thereof, whereR1 represents R5O, R5SO2, R5SO or R5S in which R5 is as defined herein;X is halo, cyano, C1-6 alkoxycarbonyl, C2-6 alkynyl, optionally substituted C6-14 aryl or an optionally substituted 5- to 7-membered heteroaromatic ring linked to thiazole via a carbon-carbon bond;R2 is hydrogen, amino, chloro, bromo, iodo, cyano, C1-6 alkoxy, C1-6 alkyl or C6-10 aryl; andR3-R7 each represent hydrogen, halogen, straight- or branched-chain C1-4 alkyl or C1-4 alkoxy, either of which is unsubstituted or substituted by one or more halogen atoms, straight- or branched-chain C1-4 alkylthio or C1-4 alkylsulphinyl, either of which is substituted by one or more halogen atoms, nitro, cyano, or straight- or branched-chain C1-4 alkylsulphonyl group which is unsubstituted or substituted by one or more halogen atoms.

    专利号:US-6545033-B1
    优先权日:1999-10-06
    标 题:Fused 1-(2,6-dichloro-4-trifluoromethylphenyl)-pyrazoles, the synthesis thereof and the use thereof as pesticides
    发明人:DHANOA DALJIT S; MEEGALLA SANATH; SOLL RICHARD M; DOLLER DARIO; SHA DEYOU; LIU RUIPING; SILVER GARY; LEE YU-KAI
    权利人:DIMENSIONAL PHARM INC
    摘要:The present invention is directed to novel pyrazole derivatives and their use as pesticidal agents. The pyrazole derivatives have Formula I:or a salt thereof, whereR1 is amino, hydrogen, alkyl, hydroxy, halo, alkoxy, alkylamino, dialkylamino, alkylthio, alkylsulfinyl, alkylsulfonyl, trifluoroalkylsulfinyl, trifluoroalkylsulfonyl, hydroxy, amino, trifluoromethyl, acetylamino, -OSO2R2, -OS(O)R2, -OC(O)R2, -OC(O)NHR2, or -NHC(O)NHR2 where R2 is C1-4 alkyl or optionally substituted aryl;X, Y and Z are each independently (CH)n, (CR3R4)n, S, S(O), or SO2, wherein n is 1-2, R3 and R4 are defined herein;Q is N or C-R6, wherein R6 is fluoro, chloro, bromo, or iodo;R5 is halo, C1-C6 alkyl, C1-C4 alkenyl, C1-C4 alkoxy, C1-C4 alkylamino, C1-C4 dialkylamino, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 trifluoroalkylsulfinyl, C1-C4 trifluoroalkylsulfonyl, hydroxy, amino, or trifluoromethyl; andwith the proviso that only one of X, Y and Z can be S, S(O) or SO2.
    成都彼样生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:028-81700200👤
    ⚠️参考联系方式
    销售经理: 鲜凤玲经理
    联系电话:028-81700200
    手机号码: 18108052721
    传真号码: 86-028-81705658
    QQ号:2850505130
    四川省成都市青羊区日月大道一段978号青羊万达3栋1单元16楼1630-2
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    四川省成都市青羊区日月大道一段978号青羊万达3栋1单元16楼1630-2
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    成都标样生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:028-81700200👤
    ⚠️参考联系方式
    销售经理: 白燕经理
    联系电话:028-81700200
    手机号码: 13308200041
    传真号码: 028-81705658
    QQ号:2851167782
    成都市清江中路63号金沙揽胜20-3
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    成都市清江中路63号金沙揽胜20-3
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    成都瑞芬思生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:18981717076👤
    ⚠️参考联系方式
    销售经理: 王红霞经理
    联系电话:18981717076
    手机号码: 18981717076
    传真号码: 028-85377359
    QQ号:2355253616
    成都市高新区科园南路88号天府生命科技园孵化楼C1栋709
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    成都市高新区科园南路88号天府生命科技园孵化楼C1栋709
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    陕西华昱生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:0917-3676029👤
    ⚠️参考联系方式
    邮件:huayu8@csxhuayu.com
    销售经理: 王婷经理
    联系电话:0917-3676029
    手机号码: 18391615700
    传真号码: 86-917-3676029
    QQ号:358294847
    陕西省宝鸡市陈仓大道2号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    陕西省宝鸡市陈仓大道2号
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Ma J, Lin C, Wen C, Xiang Z, Yang X, Wang X. Determination of bicuculline in rat plasma by liquid chromatography mass spectrometry and its application in a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Mar 15;953-954:143-6. doi: 10.1016/j.jchromb.2014.02.006. Epub 2014 Feb 18. doi: 10.1016/j.brainres.2012.03.015. Epub 2012 Mar 13. doi: 10.1016/j.saa.2011.09.022. Epub 2011 Sep 16. doi: 10.1016/j.bbr.2014.05.032. Epub 2014 May 24. doi: 10.1038/npp.2014.223. Epub 2014 Aug 28.
    7: Rysakova MP, Pavlova IV. [Behavior of high- and low-anxiety rats after modulation of GABAergic transmission in basolateral amygdala]. Ross Fiziol Zh Im I M Sechenova. 2014 Jun;100(6):736-49. Russian. doi: 10.1016/j.pbb.2015.09.010. Epub 2015 Sep 12. doi: 10.1016/j.bbr.2014.06.032. Epub 2014 Jun 21. Erratum in: J Physiol (Lond) 1995 Jun 15;485(Pt 3):873.
    13: Karson AB, Aker R, Ateş N, Onat F. Cardiovascular effects of intracerebroventricular bicuculline in rats with absence seizures. Epilepsy Res. 1999 Apr;34(2-3):231-9. doi: 10.1007/s00702-014-1211-5. Epub 2014 Apr 20. doi: 10.1016/j.ejphar.2013.08.027. Epub 2013 Sep 11.

    合成参考文献


    参考文献:10.1159/000089934
    摘要:Zarrindast MR, Noorbakhshnia M, Motamedi F, Haeri-Rohani A, Rezayof A. Effect of the GABAergic system on memory formation and state-dependent learning induced by morphine in rats. Pharmacology. 2006;76(2):93–100. doi: 10.1159/000089934.
    参考文献:10.1016/j.neuroscience.2011.06.073
    摘要:Castro A, Aguilar J, Andrés C, Felix R, Delgado-Lezama R. GABAA receptors mediate motoneuron tonic inhibition in the turtle spinal cord. Neuroscience. 2011 Sep 29;192():74–80. doi: 10.1016/j.neuroscience.2011.06.073.
    参考文献:10.1155/2011/693426
    摘要:Qian H, Ripps H. Neurovascular Interaction and the Pathophysiology of Diabetic Retinopathy. Experimental Diabetes Research. 2011;2011():1–11. doi: 10.1155/2011/693426.
    参考文献:10.1152/ajpregu.00144.2011
    摘要:Horiuchi J, Atik A, Iigaya K, McDowall LM, Killinger S, Dampney RAL. Activation of 5-hydroxytryptamine-1A receptors suppresses cardiovascular responses evoked from the paraventricular nucleus. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2011 Oct;301(4):R1088–97. doi: 10.1152/ajpregu.00144.2011.
    参考文献:10.1155/2011/935631
    摘要:Liu A, Björkman T, Stewart C, Nanan R. Pharmacological Treatment of Neonatal Opiate Withdrawal: Between the Devil and the Deep Blue Sea. International Journal of Pediatrics. 2011;2011():1–5. doi: 10.1155/2011/935631.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知